Inogen Inc (INGN)
6.75
+0.27
(+4.17%)
USD |
NASDAQ |
Apr 26, 16:00
6.75
0.00 (0.00%)
After-Hours: 20:00
Inogen Enterprise Value: 22.69M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 22.69M |
| April 24, 2024 | 35.98M |
| April 23, 2024 | 32.48M |
| April 22, 2024 | 27.82M |
| April 19, 2024 | 28.98M |
| April 18, 2024 | 36.92M |
| April 17, 2024 | 33.65M |
| April 16, 2024 | 33.18M |
| April 15, 2024 | 38.55M |
| April 12, 2024 | 43.21M |
| April 11, 2024 | 41.35M |
| April 10, 2024 | 44.15M |
| April 09, 2024 | 51.61M |
| April 08, 2024 | 21.52M |
| April 05, 2024 | 18.49M |
| April 04, 2024 | 26.65M |
| April 03, 2024 | 33.42M |
| April 02, 2024 | 36.92M |
| April 01, 2024 | 47.41M |
| March 28, 2024 | 59.78M |
| March 27, 2024 | 57.33M |
| March 26, 2024 | 52.08M |
| March 25, 2024 | 46.95M |
| March 22, 2024 | 36.45M |
| March 21, 2024 | 37.62M |
| Date | Value |
|---|---|
| March 20, 2024 | 32.25M |
| March 19, 2024 | 31.32M |
| March 18, 2024 | 31.08M |
| March 15, 2024 | 32.48M |
| March 14, 2024 | 28.98M |
| March 13, 2024 | 38.08M |
| March 12, 2024 | 34.35M |
| March 11, 2024 | 39.25M |
| March 08, 2024 | 48.58M |
| March 07, 2024 | 47.41M |
| March 06, 2024 | 35.52M |
| March 05, 2024 | 28.98M |
| March 04, 2024 | 27.35M |
| March 01, 2024 | 35.40M |
| February 29, 2024 | 26.65M |
| February 28, 2024 | 18.25M |
| February 27, 2024 | 89.40M |
| February 26, 2024 | 88.00M |
| February 23, 2024 | 85.90M |
| February 22, 2024 | 86.49M |
| February 21, 2024 | 86.95M |
| February 20, 2024 | 89.24M |
| February 16, 2024 | 101.63M |
| February 15, 2024 | 104.39M |
| February 14, 2024 | 66.76M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-50.93M
Minimum
Sep 25 2023
1.847B
Maximum
May 06 2019
565.74M
Average
488.19M
Median
Enterprise Value Benchmarks
| Oragenics Inc | 3.172M |
| Palatin Technologies Inc | 18.27M |
| Oramed Pharmaceuticals Inc | -18.77M |
| vTv Therapeutics Inc | 59.57M |
| G1 Therapeutics Inc | 170.89M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.56M |
| Revenue (Quarterly) | 75.90M |
| Total Expenses (Quarterly) | 104.88M |
| EPS Diluted (Quarterly) | -1.14 |
| Gross Profit Margin (Quarterly) | 37.10% |
| Profit Margin (Quarterly) | -34.99% |
| Earnings Yield | -65.33% |
| Normalized Earnings Yield | -48.76 |